Anaphylaxis

The Federal Aviation Administration Reauthorization Act of 2024 includes a call for updated rules on airplane medical kits and staff training in regard to anaphylaxis-related emergencies.

Healio compiled the most-read news in allergy, asthma and immunology posted in May.

Maryland lawmakers passed HB1195, or Elijah’s Law, which requires state departments to develop a set of guidelines for childcare centers to reduce the risk for anaphylactic reactions to food allergen.

Healio has compiled April’s most-read news in asthma and allergy.

Patients experienced fewer reactions that required epinephrine during oral immunotherapy with peanut allergen powder compared with other immunotherapy methods, according to a study published in Annals of Allergy, Asthma & Immunology.

Intrinsic factors such as blood type, medical history, allergies and family history contribute to the risk for developing alpha-gal syndrome, according to a study published in Annals of Allergy, Asthma & Immunology.

ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy epinephrine nasal spray — designed to treat type 1 allergic reactions such as anaphylaxis — by Oct. 2.

Immunotherapy, biologics, difficult cases, practice management and more are on the schedule of the seventh Food Allergy Support Team Annual Meeting, scheduled for Saturday and Sunday, June 21 and 22, in Dallas.

Children at high risk for reactions in oral immunotherapy for food allergy may benefit from sublingual immunotherapy before oral food challenges, according to a study published in the Journal of Allergy and Clinical Immunology: In Practice.

ARS Pharma has submitted a response letter to the FDA as it seeks approval for its neffy epinephrine nasal spray, which is designed to treat type I allergic reactions such as anaphylaxis, according to a company press release.